Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks.
Saved in:
| Title: | Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks. |
|---|---|
| Authors: | Pérez-Stachowski J; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Tortajada B; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain., Del Arco A; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Márquez E; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain., De la Torre J; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Nieto M; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain., García de Lomas JM; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Prada JL; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., García-Alegría J; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain., Olalla J; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain. |
| Source: | Infectious diseases (London, England) [Infect Dis (Lond)] 2019 Sep; Vol. 51 (9), pp. 691-693. Date of Electronic Publication: 2019 Jul 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 101650235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-4243 (Electronic) Linking ISSN: 23744243 NLM ISO Abbreviation: Infect Dis (Lond) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31272264 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of the switch of Triumeq<superscript>®</superscript> to generic (abacavir + lamivudine) + Tivicay<superscript>®</superscript>: data at 48 weeks. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pérez-Stachowski+J%22">Pérez-Stachowski J</searchLink>; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22Tortajada+B%22">Tortajada B</searchLink>; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22Del+Arco+A%22">Del Arco A</searchLink>; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22Márquez+E%22">Márquez E</searchLink>; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22De+la+Torre+J%22">De la Torre J</searchLink>; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22Nieto+M%22">Nieto M</searchLink>; b Department of Pharmacy, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22García+de+Lomas+JM%22">García de Lomas JM</searchLink>; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22Prada+JL%22">Prada JL</searchLink>; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22García-Alegría+J%22">García-Alegría J</searchLink>; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain.<br /><searchLink fieldCode="AU" term="%22Olalla+J%22">Olalla J</searchLink>; a Department of Internal Medicine, Hospital Costa del Sol , Marbella , Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101650235%22">Infectious diseases (London, England)</searchLink> [Infect Dis (Lond)] 2019 Sep; Vol. 51 (9), pp. 691-693. <i>Date of Electronic Publication: </i>2019 Jul 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101650235 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-4243 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744243%22">23744243 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis (Lond) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31272264 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/23744235.2019.1637536 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 691 Titles: – TitleFull: Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pérez-Stachowski J – PersonEntity: Name: NameFull: Tortajada B – PersonEntity: Name: NameFull: Del Arco A – PersonEntity: Name: NameFull: Márquez E – PersonEntity: Name: NameFull: De la Torre J – PersonEntity: Name: NameFull: Nieto M – PersonEntity: Name: NameFull: García de Lomas JM – PersonEntity: Name: NameFull: Prada JL – PersonEntity: Name: NameFull: García-Alegría J – PersonEntity: Name: NameFull: Olalla J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2019 Sep Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2374-4243 Numbering: – Type: volume Value: 51 – Type: issue Value: 9 Titles: – TitleFull: Infectious diseases (London, England) Type: main |
| ResultId | 1 |